<p>SupT1 cells were treated with doxycycline (500 μg/ml) for 16 hours to induce IFITM1 expression before infection with HIV-1<sub>BH10</sub> (A, B) or HIV-1<sub>NL4–3</sub> (C, D). Forty hours after infection, cells were harvested and stained with FITC-conjugated anti-p24 antibody. Infected cells were scored by flow cytometry (shown in A and C). Amounts of viruses made in the supernatants were determined by ELISA to measure HIV-1 p24/CA (shown in C and D). Results of three independent experiments are summarized in the bar graph.</p
<p>(A) Resting or pre-activated (CD3/CD28 beads, two beads per cell) CD4 T cells (1×10<sup>6</sup>) ...
<p><i>Ex vivo</i> PBMCs from chronically HIV-infected individuals were stimulated with HIV Gag pepti...
<p>(A) Gating strategy used to identify CD14 negative BDCA-2 positive CD123 positive pDCs. (B) PBMCs...
<p>(A) SupT1 cells were stably transduced to express IFITM1 under the induction by doxycycline. HIV-...
<p>(A) Alignment of IFITM1 sequences from different species. Human IFITM1 and mouse IFITM1 are highl...
<p>293T cells were transfected with expression plasmids encoding HIV-1 NL4.3 without or with increas...
<p>HeLa cells were exposed to HIV-1 (10 ng/mL p24 Ag), HIV-1 gp120 (5 µg/mL) or IFN-γ (10 ng/mL, use...
(A) Candidate anti-HIV-1 effectors that were more inhibitory than the known anti-HIV-1 effector IFIT...
<p>(a) MDM were treated with 500 IU/ml IFNα 24 hr prior to challenge with HIV-1 BaL. Cells were coll...
<p>(<b>A</b>) HIV-1-infected macrophages (with 10 days of infection) were lysed with Laemmli buffer ...
<p>LPMCs (n = 6 donors) were infected with HIV-1<sub>BaL</sub>, treated with IFNα subtypes with weak...
<p>(A) Cell-to-cell transmission between SupT1 cells that did not express IFITM1. The donor SupT1 ce...
<p>(A) Primary CD4 T cells were harvested, sorted into the resting subset, and stimulated with gp120...
<p>(A) MDM were activated by LPS in the presence of vehicle or BX-795, supernatants were collected f...
<p>PBMCs were stained with anti-CD4, anti-CD45RA, anti-FOXP3, and anti-CCR5 or anti-CXCR4 antibodies...
<p>(A) Resting or pre-activated (CD3/CD28 beads, two beads per cell) CD4 T cells (1×10<sup>6</sup>) ...
<p><i>Ex vivo</i> PBMCs from chronically HIV-infected individuals were stimulated with HIV Gag pepti...
<p>(A) Gating strategy used to identify CD14 negative BDCA-2 positive CD123 positive pDCs. (B) PBMCs...
<p>(A) SupT1 cells were stably transduced to express IFITM1 under the induction by doxycycline. HIV-...
<p>(A) Alignment of IFITM1 sequences from different species. Human IFITM1 and mouse IFITM1 are highl...
<p>293T cells were transfected with expression plasmids encoding HIV-1 NL4.3 without or with increas...
<p>HeLa cells were exposed to HIV-1 (10 ng/mL p24 Ag), HIV-1 gp120 (5 µg/mL) or IFN-γ (10 ng/mL, use...
(A) Candidate anti-HIV-1 effectors that were more inhibitory than the known anti-HIV-1 effector IFIT...
<p>(a) MDM were treated with 500 IU/ml IFNα 24 hr prior to challenge with HIV-1 BaL. Cells were coll...
<p>(<b>A</b>) HIV-1-infected macrophages (with 10 days of infection) were lysed with Laemmli buffer ...
<p>LPMCs (n = 6 donors) were infected with HIV-1<sub>BaL</sub>, treated with IFNα subtypes with weak...
<p>(A) Cell-to-cell transmission between SupT1 cells that did not express IFITM1. The donor SupT1 ce...
<p>(A) Primary CD4 T cells were harvested, sorted into the resting subset, and stimulated with gp120...
<p>(A) MDM were activated by LPS in the presence of vehicle or BX-795, supernatants were collected f...
<p>PBMCs were stained with anti-CD4, anti-CD45RA, anti-FOXP3, and anti-CCR5 or anti-CXCR4 antibodies...
<p>(A) Resting or pre-activated (CD3/CD28 beads, two beads per cell) CD4 T cells (1×10<sup>6</sup>) ...
<p><i>Ex vivo</i> PBMCs from chronically HIV-infected individuals were stimulated with HIV Gag pepti...
<p>(A) Gating strategy used to identify CD14 negative BDCA-2 positive CD123 positive pDCs. (B) PBMCs...